Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Gland Pharma jumped 5.6 percent to Rs 2,501 and formed small bodied bullish candle on the daily scale, while Schneider Electric Infrastructure climbed over 6 percent to Rs 145.3 and Inverted Hammer kind of pattern on the daily charts with above average volumes.
With the possibility of escalation in tensions in Eastern Europe due to the Russia-Ukraine war keeping investors edgy, the brokerage firm says healthy earnings visibility can act as a cushion
A cement-maker, a pharma firm and specialty chemicals company are among the top picks of broking firms for the new year
Vinay Rajani of HDFC Securities says markets are on their path to recovery, however, short-term bullish trend reversal will be confirmed only above 17,170
As the market seems to have the comfort of valuation now, it is time to lap up quality stocks, analysts point out.
The final/official list of large, mid and small-caps will be released by AMFI by the first week of January 2021, which will be effective for the February-to-July 2021 period.
Experts have a positive long-term view on the stock, given the company's strong financials and hold in the injectable business.